Clinical Trial News and Research

RSS

Intranasal influenza vaccine may help induce broader immunity in children than the traditional flu shot

MedImmune, Inc. has announced clinical data showing that a live, attenuated intranasal influenza vaccine (LAIV) may help induce broader immunity in children against drifted influenza strains when compared to the traditional flu shot (TIV).

2 May 2004

FDA approves new drug Enbrel for psoriasis

The U.S. Food and Drug Administration has approved the biologic drug etanercept (brand name Enbrel) to treat chronic, moderate to severe plaque psoriasis in adults.

1 May 2004

Gene therapy may delay Alzheimer progression

Results from a preliminary eight-patient study of gene therapy for Alzheimer’s disease are positive enough to justify a larger clinical trial, Mark H. Tuszynski, M.D., Ph.D., reported April 27 at the 56th Annual Meeting of the American Academy of Neurology. Dr. Tuszynski says that a larger trial is being planned at a major medical center in Chicago.

30 Apr 2004

Mutation of a gene involved in non-small cell lung cancer linked to drug effectiveness

Mutation of a gene involved in non-small cell lung cancer (NSCLC) increases the likelihood that the drug gefitinib (Iressa™) will show a beneficial response, researchers at the Dana-Farber Cancer Institute, the National Cancer Institute (NCI) - part of the National Institutes of Health - and two other institutions announced today in the online version of Science.

29 Apr 2004

Study shows prostate brachytherapy using ‘Radioactive Seeds’ is an effective alterantive to surgery or external radiation

Radiation oncologists and urologists at The Cleveland Clinic have performed their 1,000th prostate brachytherapy, a type of treatment in which radioactive seeds are implanted in the prostate to destroy cancerous cells.

28 Apr 2004

$Untreated postmenopausal women with osteoporosis are at risk for first spinal fracture within one year$

Untreated postmenopausal women with osteoporosis are at risk for first spinal fracture within one year

Results of a new analysis found that, without treatment, one out of 13 postmenopausal osteoporotic women who were initially fracture-free were likely to experience a spinal fracture within one year.

28 Apr 2004

Inspire announces positive results in cystic fibrosis study

Inspire Pharmaceuticals, Inc. today announced top-line results in a Phase II study of INS37217 Respiratory in patients with mild cystic fibrosis (CF) lung disease.

27 Apr 2004

Alzheimer’s drug has been shown to improve memory and cognition in multiple sclerosis (MS) patients

A drug widely used for treating dementia in Alzheimer’s patients has been shown to improve memory and cognition in multiple sclerosis (MS) patients who are mild to moderately cognitively impaired.

26 Apr 2004

Clinical trial of enzyme replacement therapy for the treatment of Gaucher disease

Transkaryotic Therapies, Inc. today announced that it has initiated a clinical trial to evaluate the safety and clinical activity of GA-GCB, its enzyme replacement therapy for the treatment of Gaucher disease.

26 Apr 2004

Polio victory remembered on 50th anniversary of Salk Vaccine field trials

Fifty years ago today, thousands of parents drove their school-age children to designated sites across the country for immunizations of an experimental vaccine that they hoped would stop, once and for all, the raging polio epidemic that was leaving young Americans paralyzed and sometimes dead. Organized and funded by the March of Dimes, this was the largest voluntary clinical trial ever undertaken.

26 Apr 2004

Spice turmeric corrects the cystic fibrosis defect

Scientists at The Hospital for Sick Children (Sick Kids) and Yale University School of Medicine have found that a compound in the spice turmeric corrects the cystic fibrosis defect in mice. This research is reported in the April 23, 2004 issue of the journal Science.

24 Apr 2004

Idebenone continues to show promise in treating Friedreich’s ataxia (FA)

Idebenone, a compound similar to coenzyme Q10, continues to show promise in treating the heart complications of Friedreich's ataxia (FA), notes correspondence published in the Feb. 10 issue of Neurology.

23 Apr 2004

Clinical trial of curcumin in people with cystic fibrosis

Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation, today announced that it is funding a clinical trial of curcumin in people with cystic fibrosis (CF).

22 Apr 2004

Turmeric corrects the cystic fibrosis defect

22 Apr 2004

Common anemia drug may protect hearts of infants undergoing surgical repair of congenital defects

Medical College of Wisconsin researchers may have promising news for the many infants who are born with a congenital heart defect serious enough to require surgery before their first birthday.

21 Apr 2004

A promising new therapy for rheumatoid arthritis

A promising new therapy for rheumatoid arthritis (RA) developed by researchers at the University of California, San Diego (UCSD) School of Medicine re-educates the body's immune system to prevent an attack against healthy joint tissue.

21 Apr 2004

FDA announces science-based approach to protecting Americans from unsafe dietary supplements

Speaking before the American Society for Pharmacology and Experimental Therapeutics (ASPET) and the American Society for Nutritional Sciences, Dr. Lester M. Crawford, Acting Commissioner of the Food and Drug Administration (FDA), today outlined the agency's science-based approach to protecting American consumers from unsafe dietary supplements.

19 Apr 2004

Proteomics helps fight colon cancer

Using new technology associated with the study of proteins, or proteomics, scientists at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), and their colleagues have made a step toward predicting which people with familial adenomatous polyposis.

19 Apr 2004

Chinese mushrooms can improve physical well-being

Nutritionists have since joined with manufacturers to produce supplements using fermentation from this rare mushroom. One such product is CordyMax®, made with a formula recognized in China as the fermented Cordyceps mushroom mycelial product. CordyMax® has been placed under intellectual property protection, and only one company has the license for it outside of China.

19 Apr 2004

On-board brain chips could help stroke and cerebral palsy victims

Cyberkinetics Inc has received U.S. Food and Drug Administration approval to begin a clinical trial in which four-square-millimetre chips will be placed beneath the skulls of paralyzed patients.

18 Apr 2004

Clinical Trial News and Research

Intranasal influenza vaccine may help induce broader immunity in children than the traditional flu shot

FDA approves new drug Enbrel for psoriasis

Gene therapy may delay Alzheimer progression

Mutation of a gene involved in non-small cell lung cancer linked to drug effectiveness

Study shows prostate brachytherapy using ‘Radioactive Seeds’ is an effective alterantive to surgery or external radiation

Untreated postmenopausal women with osteoporosis are at risk for first spinal fracture within one year

Inspire announces positive results in cystic fibrosis study

Alzheimer’s drug has been shown to improve memory and cognition in multiple sclerosis (MS) patients

Clinical trial of enzyme replacement therapy for the treatment of Gaucher disease

Polio victory remembered on 50th anniversary of Salk Vaccine field trials

Spice turmeric corrects the cystic fibrosis defect

Idebenone continues to show promise in treating Friedreich’s ataxia (FA)

Clinical trial of curcumin in people with cystic fibrosis

Turmeric corrects the cystic fibrosis defect

Common anemia drug may protect hearts of infants undergoing surgical repair of congenital defects

A promising new therapy for rheumatoid arthritis

FDA announces science-based approach to protecting Americans from unsafe dietary supplements

Proteomics helps fight colon cancer

Chinese mushrooms can improve physical well-being

On-board brain chips could help stroke and cerebral palsy victims

eBook: Using iPSCs models for human disease research and drug discovery eBook

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest Life Science News